Genome-wide association study for radiographic vertebral fractures: A potential role for the 16q24 BMD locus

Bone

Volumn 59, Issue , 2014, Pages 20-27

  Oei, Ling ^a,b   Estrada, Karol ^a,b   Duncan, Emma L ^c,d   Christiansen, Claus ^e   Liu, Ching Ti ^f   Langdahl, Bente L ^g   Obermayer Pietsch, Barbara ^h   Riancho, José A ^i,j   Prince, Richard L ^k,l   van Schoor, Natasja M ^m   McCloskey, Eugene ^n,o   Hsu, Yi Hsiang ^p,q   Evangelou, Evangelos ^r,s   Ntzani, Evangelia ^r   Evans, David M ^t   Alonso, Nerea ^u   Husted, Lise B ^g   Valero, Carmen ^i,j   Hernandez, Jose L ^i,j   Lewis, Joshua R ^k,l   Kaptoge, Stephen K ^v   Zhu, Kun ^k,l   Cupples, L Adrienne ^f,w   Medina Gómez, Carolina ^a,b   Vandenput, Liesbeth ^x   Kim, Ghi Su ^y   Lee, Seung Hun ^y   Castaño Betancourt, Martha C ^a,b   Oei, Edwin H G ^a   Martinez, Josefina ^z   Daroszewska, Anna ^u   van der Klift, Marjolein ^a   Mellström, Dan ^x   Herrera, Lizbeth ^a   Karlsson, Magnus K ^aa,ab   Hofman, Albert ^a   Ljunggren, Östen ^ac   Pols, Huibert A P ^a   Stolk, Lisette ^a,b   van Meurs, Joyce B J ^a,b   Ioannidis, John P A ^r,ad   Zillikens, M Carola ^a,b   Lips, Paul ^m   Karasik, David ^p,q   Uitterlinden, André G ^a,b   Styrkarsdottir, Unnur ^ae   Brown, Matthew A ^c   Koh, Jung Min ^x   Richards, J Brent ^s,af   Reeve, Jonathan ^ag   Ohlsson, Claes ^x   Ralston, Stuart H ^u   Kiel, Douglas P ^p,q   Rivadeneira, Fernando ^a,b   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Genomics Initiative   (Netherlands)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

ⁱ UNIVERSITY OF CANTABRIA   (Spain)

^j HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^m VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^o UNIVERSITY OF SHEFFIELD   (United Kingdom)

^p Hebrew SeniorLife Institute for Aging Research   (United States)

^q HARVARD MEDICAL SCHOOL   (United States)

^r UNIVERSITY OF IOANNINA   (Greece)

^s KING'S COLLEGE LONDON   (United Kingdom)

^t UNIVERSITY OF BRISTOL   (United Kingdom)

^u UNIVERSITY OF EDINBURGH   (United Kingdom)

^v UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^w FRAMINGHAM HEART STUDY   (United States)

^x UNIVERSITY OF GOTHENBURG   (Sweden)

^y University of Ulsan College of Medicine   (South Korea)

^z HOSPITAL DE LAREDO   (Spain)

^aa LUND UNIVERSITY   (Sweden)

^ab LUND UNIVERSITY HOSPITAL   (Sweden)

^ac UPPSALA UNIVERSITY   (Sweden)

^ad STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ae DECODE GENETICS   (Iceland)

^af MCGILL UNIVERSITY   (Canada)

^ag UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

FOXC2; GEFOS consortium; Genetics of osteoporosis; Genome wide association study; Vertebral fracture risk

Indexed keywords

ADULT; AGED; AGING; ALLELE; ARTICLE; BONE DENSITY; CHROMOSOME 16Q; CONTROLLED STUDY; FEMALE; FOXC2 GENE; FRAGILITY FRACTURE; GENE; GENE CLUSTER; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PHENOTYPE; RADIOGRAPHIC VERTEBRAL FRACTURE; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SPINE FRACTURE;

AGED; BONE DENSITY; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SPINAL FRACTURES;

EID: 84887568962     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2013.10.015     Document Type: Article

References (86)

1. Szulc P., Bouxsein M.L. Overview of osteoporosis: epidemiology and clinical management. Vertebral fracture initiative resource document 2011.
2. Brunton S., Carmichael B., Gold D., Hull B., Kauffman T., Papaioannou A., et al. Vertebral compression fractures in primary care: recommendations from a consensus panel. J Fam Pract 2005, 54:781-788.
3. Samelson E.J., Hannan M.T., Zhang Y., Genant H.K., Felson D.T., Kiel D.P. Incidence and risk factors for vertebral fracture in women and men: 25-year follow-up results from the population-based Framingham study. J Bone Miner Res 2006, 21:1207-1214.
4. Van der Klift M., De Laet C.E., McCloskey E.V., Hofman A., Pols H.A. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 2002, 17:1051-1056.
5. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002, 17:716-724.
6. Burger H., Van Daele P.L., Grashuis K., Hofman A., Grobbee D.E., Schutte H.E., et al. Vertebral deformities and functional impairment in men and women. J Bone Miner Res 1997, 12:152-157.
7. Ross P.D. Clinical consequences of vertebral fractures. Am J Med 1997, 103:30S-42S. [discussion 42S-43S].
8. Nevitt M.C., Ettinger B., Black D.M., Stone K., Jamal S.A., Ensrud K., et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med 1998, 128:793-800.
9. Gold D.T. The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone 1996, 18:185S-189S.
10. Oleksik A., Lips P., Dawson A., Minshall M.E., Shen W., Cooper C., et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res 2000, 15:1384-1392.
11. Oleksik A.M., Ewing S., Shen W., van Schoor N.M., Lips P. Impact of incident vertebral fractures on health related quality of life (HRQOL) in postmenopausal women with prevalent vertebral fractures. Osteoporos Int 2005, 16:861-870.
12. Bliuc D., Nguyen N.D., Milch V.E., Nguyen T.V., Eisman J.A., Center J.R. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 2009, 301:513-521.
13. Ensrud K.E., Thompson D.E., Cauley J.A., Nevitt M.C., Kado D.M., Hochberg M.C., et al. Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. J Am Geriatr Soc 2000, 48:241-249.
14. Burge R., Dawson-Hughes B., Solomon D.H., Wong J.B., King A., Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007, 22:465-475.
15. Ström O., Borgström F., Kanis J.A., Compston J., Cooper C., McCloskey E.V., et al. Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 2011, 10.1007/s11657-011-0060-1.
16. Melton L.J., Atkinson E.J., Cooper C., O'Fallon W.M., Riggs B.L. Vertebral fractures predict subsequent fractures. Osteoporos Int 1999, 10:214-221.
17. Black D.M., Arden N.K., Palermo L., Pearson J., Cummings S.R. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. J Bone Miner Res 1999, 14:821-828. Study of Osteoporotic Fractures Research Group.
18. Ralston S.H., Uitterlinden A.G. Genetics of osteoporosis. Endocr Rev 2010, 31:629-662.
19. Liu C.T., Karasik D., Zhou Y., Hsu Y.H., Genant H.K., Broe K.E., et al. Heritability of prevalent vertebral fracture and volumetric bone mineral density and geometry at the lumbar spine in three generations of the Framingham study. J Bone Miner Res 2011, 27:954-958.
20. Kanis J.A., Johansson H., Oden A., Johnell O., De Laet C., Eisman J.A., et al. A family history of fracture and fracture risk: a meta-analysis. Bone 2004, 35:1029-1037.
21. Manolio T.A. Genomewide association studies and assessment of the risk of disease. N Engl J Med 2010, 363:166-176.
22. Estrada K., Styrkarsdottir U., Evangelou E., Hsu Y.H., Duncan E.L., Ntzani E.E., et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 2012, 44:491-501.
23. Rivadeneira F., Styrkarsdottir U., Estrada K., Halldorsson B.V., Hsu Y.H., Richards J.B., et al. Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 2009, 41:1199-1206.
24. Richards J.B., Zheng H.F., Spector T.D. Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet 2012, 13:576-588.
25. Hofman A., van Duijn C.M., Franco O.H., Ikram M.A., Janssen H.L., Klaver C.C., et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011, 26:657-686.
26. Langdahl B.L., Uitterlinden A.G., Ralston S.H., Trikalinos T.A., Balcells S., Brandi M.L., et al. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: the GENOMOS study. Bone 2008, 42:969-981.
27. Ralston S.H., Uitterlinden A.G., Brandi M.L., Balcells S., Langdahl B.L., Lips P., et al. Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med 2006, 3:e90.
28. Duncan E.L., Danoy P., Kemp J.P., Leo P.J., McCloskey E., Nicholson G.C., et al. Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet 2011, 7:e1001372.
29. Sims A.M., Shephard N., Carter K., Doan T., Dowling A., Duncan E.L., et al. Genetic analyses in a sample of individuals with high or low BMD shows association with multiple Wnt pathway genes. J Bone Miner Res 2008, 23:499-506.
30. Henry M.J., Pasco J.A., Korn S., Gibson J.E., Kotowicz M.A., Nicholson G.C. Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int 2010, 21:909-917.
31. Henry M.J., Pasco J.A., Nicholson G.C., Seeman E., Kotowicz M.A. Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 2000, 3:261-268.
32. McCloskey E.V., Beneton M., Charlesworth D., Kayan K., deTakats D., Dey A., et al. Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 2007, 22:135-141.
33. Harslof T., Husted L.B., Carstens M., Stenkjaer L., Langdahl B.L. Genotypes and haplotypes of the estrogen receptor genes, but not the retinoblastoma-interacting zinc finger protein 1 gene, are associated with osteoporosis. Calcif Tissue Int 2010, 87:25-35.
34. Dobnig H., Piswanger-Solkner J.C., Roth M., Obermayer-Pietsch B., Tiran A., Strele A., et al. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 2006, 91:3355-3363.
35. Martinez J., Olmos J.M., Hernandez J.L., Pinedo G., Llorca J., Obregon E., et al. Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study. Clin Chim Acta 2009, 409:70-74.
36. Olmos J.M., Hernandez J.L., Martinez J., Pariente E., Llorca J., Gonzalez-Macias J. Bone turnover markers in Spanish adult men: the Camargo cohort study. Clin Chim Acta 2010, 411:1511-1515.
37. Riancho J.A., Valero C., Naranjo A., Morales D.J., Sanudo C., Zarrabeitia M.T. Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis. J Clin Endocrinol Metab 2007, 92:660-665.
38. Zarrabeitia M.T., Hernandez J.L., Valero C., Zarrabeitia A., Amado J.A., Gonzalez-Macias J., et al. Adiposity, estradiol, and genetic variants of steroid-metabolizing enzymes as determinants of bone mineral density. Eur J Endocrinol 2007, 156:117-122.
39. Prince R.L., Devine A., Dhaliwal S.S., Dick I.M. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 2006, 166:869-875.
40. Richards J.B., Leslie W.D., Joseph L., Siminoski K., Hanley D.A., Adachi J.D., et al. Changes to osteoporosis prevalence according to method of risk assessment. J Bone Miner Res 2007, 22:228-234.
41. Richards J.B., Papaioannou A., Adachi J.D., Joseph L., Whitson H.E., Prior J.C., et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007, 167:188-194.
42. Tenenhouse A., Joseph L., Kreiger N., Poliquin S., Murray T.M., Blondeau L., et al. Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000, 11:897-904.
43. Mosekilde L., Hermann A.P., Beck-Nielsen H., Charles P., Nielsen S.P., Sorensen O.H. The Danish Osteoporosis Prevention Study (DOPS): project design and inclusion of 2000 normal perimenopausal women. Maturitas 1999, 31:207-219.
44. Ismail A.A., O'Neill T.W., Cockerill W., Finn J.D., Cannata J.B., Hoszowski K., et al. Validity of self-report of fractures: results from a prospective study in men and women across Europe. EPOS Study Group. European Prospective Osteoporosis Study Group. Osteoporos Int 2000, 11:248-254.
45. O'Neill T.W., Felsenberg D., Varlow J., Cooper C., Kanis J.A., Silman A.J. The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 1996, 11:1010-1018.
46. Dawber T.R., Meadors G.F., Moore F.E. Epidemiological approaches to heart disease: the Framingham study. Am J Public Health Nations Health 1951, 41:279-281.
47. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., Castelli W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 1979, 110:281-290.
48. Splansky G.L., Corey D., Yang Q., Atwood L.D., Cupples L.A., Benjamin E.J., et al. The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol 2007, 165:1328-1335.
49. Koh J.M., Oh B., Lee J.Y., Lee J.K., Kimm K., Park B.L., et al. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women. J Bone Miner Res 2007, 22:1752-1758.
50. Deeg D.J., van Tilburg T., Smit J.H., de Leeuw E.D. Attrition in the Longitudinal Aging Study Amsterdam. The effect of differential inclusion in side studies. J Clin Epidemiol 2002, 55:319-328.
51. Mellstrom D., Johnell O., Ljunggren O., Eriksson A.L., Lorentzon M., Mallmin H., et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res 2006, 21:529-535.
52. Bagger Y.Z., Rasmussen H.B., Alexandersen P., Werge T., Christiansen C., Tanko L.B. Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?. Osteoporos Int 2007, 18:505-512.
53. McCloskey E.V., Spector T.D., Eyres K.S., Fern E.D., O'Rourke N., Vasikaran S., et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 1993, 3:138-147.
54. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8:1137-1148.
55. The International HapMap Project. Nature 2003, 426:789-796.
56. Altshuler D.M., Gibbs R.A., Peltonen L., Dermitzakis E., Schaffner S.F., Yu F., et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010, 467:52-58.
57. Li Y., Willer C., Sanna S., Abecasis G. Genotype imputation. Annu Rev Genomics Hum Genet 2009, 10:387-406.
58. Li Y., Willer C.J., Ding J., Scheet P., Abecasis G.R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 2010, 34:816-834.
59. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38:904-909.
60. Estrada K., Abuseiris A., Grosveld F.G., Uitterlinden A.G., Knoch T.A., Rivadeneira F. GRIMP: a web- and grid-based tool for high-speed analysis of large-scale genome-wide association using imputed data. Bioinformatics 2009, 25:2750-2752.
61. Willer C.J., Li Y., Abecasis G.R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010, 26:2190-2191.
62. Han B., Eskin E. Random-effects model aimed at discovering associations in meta-analysis of genome-wide association studies. Am J Hum Genet 2011, 88:586-598.
63. Stankiewicz P., Sen P., Bhatt S.S., Storer M., Xia Z., Bejjani B.A., et al. Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet 2009, 84:780-791.
64. Nifuji A., Miura N., Kato N., Kellermann O., Noda M. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells. J Bone Miner Res 2001, 16:1765-1771.
65. Kim S.H., Cho K.W., Choi H.S., Park S.J., Rhee Y., Jung H.S., et al. The forkhead transcription factor Foxc2 stimulates osteoblast differentiation. Biochem Biophys Res Commun 2009, 386:532-536.
66. Winnier G.E., Hargett L., Hogan B.L. The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo. Genes Dev 1997, 11:926-940.
67. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
68. Hoover R.N. The evolution of epidemiologic research: from cottage industry to "big" science. Epidemiology 2007, 18:13-17.
69. Panagiotou O.A., Ioannidis J.P. What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations. Int J Epidemiol 2012, 41:273-286.
70. Ioannidis J.P. Why most discovered true associations are inflated. Epidemiology 2008, 19:640-648.
71. Kraft P., Zeggini E., Ioannidis J.P. Replication in genome-wide association studies. Stat Sci 2009, 24:561-573.
72. Zhong H., Prentice R.L. Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. Genet Epidemiol 2010, 34:78-91.
73. Lohmueller K.E., Pearce C.L., Pike M., Lander E.S., Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177-182.
74. Montpetit A., Nelis M., Laflamme P., Magi R., Ke X., Remm M., et al. An evaluation of the performance of tag SNPs derived from HapMap in a Caucasian population. PLoS Genet 2006, 2:e27.
75. Chen F., Stram D.O., Le Marchand L., Monroe K.R., Kolonel L.N., Henderson B.E., et al. Caution in generalizing known genetic risk markers for breast cancer across all ethnic/racial populations. Eur J Hum Genet 2011, 19:243-245.
76. He J., Wilkens L.R., Stram D.O., Kolonel L.N., Henderson B.E., Wu A.H., et al. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol Biomarkers Prev 2011, 20:70-81.
77. Sim X., Ong R.T., Suo C., Tay W.T., Liu J., Ng D.P., et al. Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia. PLoS Genet 2011, 7:e1001363.
78. Stromberg U., Bjork J., Vineis P., Broberg K., Zeggini E. Ranking of genome-wide association scan signals by different measures. Int J Epidemiol 2009, 38:1364-1373.
79. Oei L., Rivadeneira F., Ly F., Breda S.J., Zillikens M.C., Hofman A., et al. Review of radiological scoring methods of osteoporotic vertebral fractures for clinical and research settings. Eur Radiol 2013, 23(2):476-486.
80. Puisto V., Heliovaara M., Impivaara O., Jalanko T., Kroger H., Knekt P., et al. Severity of vertebral fracture and risk of hip fracture: a nested case-control study. Osteoporos Int 2011, 22:63-68.
81. Jiang G., Eastell R., Barrington N.A., Ferrar L. Comparison of methods for the visual identification of prevalent vertebral fracture in osteoporosis. Osteoporos Int 2004, 15:887-896.
82. Kerkhof H.J., Meulenbelt I., Akune T., Arden N.K., Aromaa A., Bierma-Zeinstra S.M., et al. Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium. Osteoarthritis Cartilage 2011, 19:254-264.
83. Reeve J., Lunt M., Felsenberg D., Silman A.J., Scheidt-Nave C., Poor G., et al. Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2003, 18:1664-1673.
84. Felsenberg D., Silman A.J., Lunt M., Armbrecht G., Ismail A.A., Finn J.D., et al. Incidence of vertebral fracture in Europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res 2002, 17:716-724.
85. Lunt M., Ismail A.A., Felsenberg D., Cooper C., Kanis J.A., Reeve J., et al. Defining incident vertebral deformities in population studies: a comparison of morphometric criteria. Osteoporos Int 2002, 13:809-815.
86. Lunt M., Gowin W., Johnell, Armbrecht G., Felsenberg D. A statistical method to minimize magnification errors in serial vertebral radiographs. Osteoporos Int 2001, 12:909-13.